To Evaluate the Effectiveness and Safety of an Artificial Intelligence-assisted System in Colonoscopy in a Real-world Obsevational Multicenter Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• age \> 50 years old;

• required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy;

• voluntarily sign informed consent;

• Commitment to abide by the study procedures and cooperate with the implementation of the whole process of the study.

Locations
Other Locations
China
Renmin Hospital of Wuhan Univercity
RECRUITING
Wuhan
Contact Information
Primary
Honggang Yu, Doctor
wjlnsm@163.com
18771146096
Time Frame
Start Date: 2024-05-20
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 7500
Treatments
AI-assisted group
Group with AI assistance
Control group
Group without AI assistance
Related Therapeutic Areas
Sponsors
Leads: Renmin Hospital of Wuhan University

This content was sourced from clinicaltrials.gov